APA

Singh S. K., Vobbalareddy S., Kalleda S. R., Casturi S. R., Datla S. R., Mamidi R. N. V. S., Mullangi R., Ramanujam R., Yeleswarapu K. R. & Iqbal J. (20070202). Identification of 2-hydroxymethyl-4-[5-(4-methoxyphenyl)-3-trifluoromethyl-pyrazol-1-yl]-N-propionylbenzenesulfonamide sodium as a potential COX-2 inhibitor for oral and parenteral administration. : Bioorganic & medicinal chemistry.

Chicago

Singh Sunil Kumar, Vobbalareddy Saibaba, Kalleda Srinivasa Rao, Casturi Seshagiri Rao, Datla Srinivasa Raju, Mamidi Rao N V S, Mullangi Ramesh, Ramanujam Rajagopalan, Yeleswarapu Koteswar Rao and Iqbal Javed. 20070202. Identification of 2-hydroxymethyl-4-[5-(4-methoxyphenyl)-3-trifluoromethyl-pyrazol-1-yl]-N-propionylbenzenesulfonamide sodium as a potential COX-2 inhibitor for oral and parenteral administration. : Bioorganic & medicinal chemistry.

Harvard

Singh S. K., Vobbalareddy S., Kalleda S. R., Casturi S. R., Datla S. R., Mamidi R. N. V. S., Mullangi R., Ramanujam R., Yeleswarapu K. R. and Iqbal J. (20070202). Identification of 2-hydroxymethyl-4-[5-(4-methoxyphenyl)-3-trifluoromethyl-pyrazol-1-yl]-N-propionylbenzenesulfonamide sodium as a potential COX-2 inhibitor for oral and parenteral administration. : Bioorganic & medicinal chemistry.

MLA

Singh Sunil Kumar, Vobbalareddy Saibaba, Kalleda Srinivasa Rao, Casturi Seshagiri Rao, Datla Srinivasa Raju, Mamidi Rao N V S, Mullangi Ramesh, Ramanujam Rajagopalan, Yeleswarapu Koteswar Rao and Iqbal Javed. Identification of 2-hydroxymethyl-4-[5-(4-methoxyphenyl)-3-trifluoromethyl-pyrazol-1-yl]-N-propionylbenzenesulfonamide sodium as a potential COX-2 inhibitor for oral and parenteral administration. : Bioorganic & medicinal chemistry. 20070202.